Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

NCT01918371 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01918371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01918371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
August 2, 2013
Completion date
September 4, 2014
Enrollment
323 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, retinal vein occlusion